Switching From Insulin Bolus Treatment to GLP-1 RAs Added to Continued Basal Insulin in People With Type 2 Diabetes on Basal-Bolus Insulin

被引：6
|
作者：
Bolli, Geremia B. [1 ]
Porcellati, Francesca [1 ]
Meier, Juris J. [2 ]
机构：
[1] Perugia Univ, Sch Med, Dept Med, Sect Endocrinol & Metab, Perugia, Italy
[2] Katholisches Klinikum Bochum, Diabet Zentrum Bochum Hattingen, Bochum, Germany
来源：
DIABETES CARE | 2020年 / 43卷 / 10期
关键词：
PEPTIDE-1 RECEPTOR AGONIST; GLUCOSE-METABOLISM; THERAPY; LIRAGLUTIDE; LIXISENATIDE; REPLACEMENT; ALBIGLUTIDE; ANALOG; PLUS;
D O I：
10.2337/dci20-0038
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2333 / 2335
页数：3
相关论文
共 50 条
  • [1] An economic assessment of analogue basal-bolus insulin versus human basal-bolus insulin in subjects with type 1 diabetes in the UK
    Palmer, Andrew J.
    Valentine, William J.
    Ray, Joshua A.
    Foos, Volker
    Lurati, Francesco
    Smith, Inger
    Lammert, Morten
    Roze, Stephane
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (04) : 895 - 901
  • [2] GLP-1 receptor agonist added to insulin versus basal-plus or basal-bolus insulin therapy in type 2 diabetes: A systematic review and meta-analysis
    Castellana, Marco
    Cignarelli, Angelo
    Brescia, Francesco
    Laviola, Luigi
    Giorgino, Francesco
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2019, 35 (01)
  • [3] ADAPTIVE BASAL-BOLUS ADVISOR FOR INSULIN TREATED PEOPLE WITH TYPE 2 DIABETES
    Panagiotou, M.
    Brigato, L.
    De Galan, B.
    Mougiakakou, S.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A90 - A91
  • [4] Insulin detemir and insulin aspart:: a promising basal-bolus regimen for type 2 diabetes
    Raslová, K
    Bogoev, M
    Raz, I
    Leth, G
    Gall, MA
    Hancu, N
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2004, 66 (02) : 193 - 201
  • [5] Effectiveness of one-year insulin glargine and insulin glulisine basal-bolus treatment in people with type 2 diabetes
    Jermendy Gyorgy
    Kovacs Gabor
    [J]. ORVOSI HETILAP, 2018, 159 (50) : 2122 - 2128
  • [6] THE COSTS OF INTENSIFICATION FROM BASAL INSULIN TO BASAL-BOLUS IN TYPE 2 DIABETES: A SURVEY OF PHYSICIANS
    Pfeiffer, K. M.
    Basse, A.
    Brod, M.
    [J]. VALUE IN HEALTH, 2018, 21 : S74 - S74
  • [7] Experience with Insulin-Bolus Calculator in Diabetes Type 1 Patients in Treatment on Basal-Bolus Regimen
    Tejera, Cristina
    Miguel Morales, Francisco
    Maria Lopez, Ana
    Galvan, Beatriz
    Delgado, Esther
    Beato, Pilar
    Hernandez, Virginia
    [J]. DIABETES, 2014, 63 : A596 - A596
  • [8] Clinical Impact of GLP-1 receptor agonists in veterans receiving basal-bolus insulin
    Hopton, Olivia M.
    Waterbury, Nancee, V
    Egge, Jason A.
    Lund, Brian C.
    [J]. PHARMACOTHERAPY, 2022, 42 (01): : 45 - 52
  • [9] Efficacy of Insulin Degludec as Basal-Bolus Therapy After Switching from Insulin Glargine or Insulin Detemir in Young Persons with Type 1 Diabetes
    Urakami, Tatsuhiko
    Habu, Masako
    Okuno, Misako
    Suzuki, Junichi
    Takahashi, Shori
    [J]. DIABETES, 2014, 63 : A323 - A323
  • [10] Insulin pumps: Beyond basal-bolus
    Millstein, Richard
    Becerra, Nancy Mora
    Shubrook, Jay H.
    [J]. CLEVELAND CLINIC JOURNAL OF MEDICINE, 2015, 82 (12) : 835 - 842
12345